AU2003255022A1 - Remedies for schizophrenia - Google Patents

Remedies for schizophrenia

Info

Publication number
AU2003255022A1
AU2003255022A1 AU2003255022A AU2003255022A AU2003255022A1 AU 2003255022 A1 AU2003255022 A1 AU 2003255022A1 AU 2003255022 A AU2003255022 A AU 2003255022A AU 2003255022 A AU2003255022 A AU 2003255022A AU 2003255022 A1 AU2003255022 A1 AU 2003255022A1
Authority
AU
Australia
Prior art keywords
remedies
schizophrenia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003255022A
Inventor
Morihiro Mitsuya
Mitsuru Ohkubo
Hisashi Ohta
Akio Sato
Takeshi Tanaka
Naohiro Tsukamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Publication of AU2003255022A1 publication Critical patent/AU2003255022A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003255022A 2002-08-14 2003-08-13 Remedies for schizophrenia Abandoned AU2003255022A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002236267 2002-08-14
JP2002-236267 2002-08-14
PCT/JP2003/010286 WO2004016287A1 (en) 2002-08-14 2003-08-13 Remedies for schizophrenia

Publications (1)

Publication Number Publication Date
AU2003255022A1 true AU2003255022A1 (en) 2004-03-03

Family

ID=31884404

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003255022A Abandoned AU2003255022A1 (en) 2002-08-14 2003-08-13 Remedies for schizophrenia

Country Status (2)

Country Link
AU (1) AU2003255022A1 (en)
WO (1) WO2004016287A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020127735A1 (en) 2018-12-20 2020-06-25 Intervet International B.V. New methods of producing (2-amino-4-[6-(4-fluorophenyl)-2-[(4-methyl-1-piperazinyl)methyl]imidazo[2,1-b]thiazol-5-yl]-pyrimidine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1059090A4 (en) * 1998-03-03 2002-02-27 Yamanouchi Pharma Co Ltd Remedies for brain infarction
AU2241400A (en) * 1999-04-06 2000-10-12 Yamanouchi Pharmaceutical Co., Ltd. Novel thiazolobenzoimidazole derivative
EP1074549B1 (en) * 1999-08-06 2003-11-19 F. Hoffmann-La Roche Ag Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors
JP2002105085A (en) * 2000-09-28 2002-04-10 Yamanouchi Pharmaceut Co Ltd New imidazothiazole derivative

Also Published As

Publication number Publication date
WO2004016287A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
EP2295053B8 (en) Novel 2H-chromen-2-one-3-carboxamides for medical uses
AU2003266949A1 (en) Compounds
AU2003221098A1 (en) Oligofluorenylene compounds
AU2003266227A1 (en) Crossmember
AU2003304507A1 (en) Anti-coronavirus agent
AU2003283626A1 (en) Catheter
AU2003272902A1 (en) Remedies
AU2003278369A1 (en) 3-cyano-quinoline derivatives
AU2003296564A1 (en) 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives
AU2003222659A1 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
AU2003216859A1 (en) Amidoacetonitrile compounds
AU2003228198A1 (en) Av-fistula bandage
AU2003234131A1 (en) 5-o-mycaminosyltylonide derivatives
AU2003281179A1 (en) Remedies for pigmentation
AU2003272570A1 (en) Dressing for catheter assembly
AU2003281316A1 (en) Parts for fluid
AU2003220825A1 (en) Remedy for glioblastoma
AU2003272901A1 (en) Remedies
AU2003221050A1 (en) Remedy for hypermyotonia
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2003244140A1 (en) Catheter
AU2003236039A1 (en) Preventives/remedies for hotflash
AU2003207181A1 (en) Microorganism-trapping agent
AU2003238180A1 (en) 2-naphtamide derivatives
AU2003273398A1 (en) Aroyl-piperidine derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase